An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
Nina Friis‐Møller(University of Copenhagen), Matthew Law(UNSW Sydney), Andrew Phillips(Wake Forest University), Colette Smith(MRC Clinical Trials Unit at UCL), Ole Kirk(University of Copenhagen), Éric Fontas(Université Côte d'Azur), François Dabis(Université de Bordeaux), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Caroline Sabin(Primary Health Care), Peter Reiss(Amsterdam Institute for Global Health and Development), Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre), Lene Ryom(University of Copenhagen)
Cited by 237
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k